AbbVie is a global biopharmaceutical company founded in 2013 as a separate entity from Abbott Laboratories. Operating in over 170 countries with approximately 57,000 employees worldwide, the company discovers and develops innovative medicines addressing complex health issues across immunology, oncology, and neuroscience.
The company's work centres on drug discovery, clinical research, and therapeutic development. AbbVie combines cutting-edge research and development with personalised patient support programmes, aiming to transform standards of care in its focus areas. The organisation operates at significant scale, with substantial resources dedicated to bringing new treatments to patients globally.